Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Return on Equity [ROE] (2018 - 2026)

Updated

Moderna (MRNA) reported Return on Equity [ROE] of -44.48% for Q2 2026, down 14.65 percentage points from -29.83% a year earlier and down 4.70 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Moderna posted Return on Equity [ROE] of -28.87%, down 0.10 percentage points from FY2024.

  • Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +11.12 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -28.77% in FY2024 (-0.18 pp), -28.59% in FY2023 (-78.86 pp), 50.27% in FY2022 (-95.81 pp) and 146.08% in FY2021 (+186.07 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2024.
  • Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of +0.12 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 128.63 percentage points); the low point was Q3 2023 (a drop of 88.20 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -39.78% (Q1 2026), -31.39% (Q4 2025) and -33.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 19.33%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.63%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 21.60%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -31.17%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 4.66%
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn -44.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.48%
Mar 31, 2026 -39.78%
Dec 31, 2025 -31.39%
Sep 30, 2025 -33.27%
Jun 30, 2025 -29.83%
Mar 31, 2025 -32.02%
Dec 31, 2024 -31.20%
Sep 30, 2024 -18.82%
Jun 30, 2024 -47.84%
Mar 31, 2024 -44.75%
Dec 31, 2023 -34.52%
Sep 30, 2023 -22.80%
Jun 30, 2023 6.74%
Mar 31, 2023 25.19%
Dec 31, 2022 45.06%
Sep 30, 2022 65.40%
Jun 30, 2022 80.18%
Mar 31, 2022 93.77%
Dec 31, 2021 100.56%
Sep 30, 2021 83.92%
API Access

Moderna Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY